The outbreak of COVID-19 in France led to the disruption of regular schedules and habits, with consumers required to stay at home as much as possible from March-May, working from home remotely. These disruptions, along with the outbreak of the virus itself, created an increase in stress and worry for consumers, with many worried about finances and the uncertain future.
Value growth for digestive remedies is expected to align to value growth recorded in 2019, despite an initial surge in sales during Q1 and Q2 of 2020. This initial demand was due to consumers stockpiling goods, as well as lifestyle changes due to home seclusion, that disrupted some consumers digestive systems.
In order, Johnson & Johnson Santé Beauté France, Teva Santé SAS and Sanofi are the three leaders of the digestive remedies landscape. Johnson & Johnson benefits from offering two popular OTC drugs, Imodium in the diarrheal landscape, and Microloax in laxatives.
Digestive remedies is expected to record more robust growth in 2021 compared to 2020, with value growth set to increase year-on-year over the forecast period. In 2021, a rise in growth will be seen from paediatric products, antiacids and motion sickness remedies.
In 2020, the journal Prescrire published a blacklist of medicines to avoid, including the OTC diarrhoeal remedy Smecta, from Ipsen SA. The publication states that there is a risk due to the use of medicinal clay, which can contaminate the product.
French consumers are growing increasingly reluctant to take over-the-counter medications, with many shifting to natural remedies. This is especially the case since the systematic use of anti-diarrheal medications is often not recommended, whereas rehydration orally with a suitable diet is.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in France with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in France, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Digestive Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page